Qube Research & Technologies Ltd

Position in VSTM — Verastem, Inc.

CIK 1729829 LONDON, X0

Position in VSTM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,220,824

-$1,602,124 QoQ

Shares Held

1,628,488

+10.3% QoQ

Ownership

1.80%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#20

of 158 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. VSTM ranks #71 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,220,824	1,628,488	+10.3%	Shares	Sole	2026-08-14
2026-03-31	$7,822,948	1,476,028	+479.1%	Shares	Sole	2026-05-15
2025-12-31	$1,967,828	254,900	-9.7%	Shares	Sole	2026-02-17
2025-06-30	$1,171,246	282,228	+250.0%	Shares	Sole	2025-08-14
2024-03-31	$951,386	80,626	+3306.3%	Shares	Sole	2024-05-14
2023-12-31	$19,267	2,367	-80.5%	Shares	Sole	2024-02-13
2022-12-31	$4,856	12,142	-89.1%	Shares	Sole	2023-02-14
2022-09-30	$94,361	111,014	+21.2%	Shares	Sole	2022-11-14
2022-06-30	$106,254	91,599	-45.6%	Shares	Sole	2022-08-15
2021-12-31	$345,060	168,322	+154.2%	Shares	Sole	2022-02-10
2021-06-30	$269,523	66,222	-35.9%	Shares	Sole	2021-08-13
2020-06-30	$177,823	103,386	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.